Shareholder Activism

Elliott flexes its two biggest muscles at Sempra

18 September 2018

The $32 bln utility agreed to add two new board members and says it will review a break-up. Meanwhile, Elliott’s lawyers won back a $275 mln fee from when Sempra bought Texas utility Oncor. Paul Singer’s fund specializes in persuasion and litigation. This time, both paid off.

Loeb needs Campbell Soup to taste more like Heinz

11 September 2018

The activist is trying to replace the board at the indebted $12 bln food group. He’s backing off demands for a sale, though. That leaves improving lackluster margins. Success could bring an investment win, but it’s a grind more suited to Kraft Heinz backers 3G Capital.

Elliott’s new Hyundai push will be hard to ignore

7 September 2018

The U.S. hedge fund has called out a lack of progress in the South Korean conglomerate's overhaul. That looks justified: it has yet to come back after investors nixed a $9 bln plan in May. As regulators step up pressure to reform, Hyundai may not be able to stall much longer.

Vivendi gives Elliott a taste of activist medicine

6 September 2018

Telecom Italia is turning into the U.S. fund’s worst big investment in Europe. Vivendi, which used to run the telco and is its biggest investor, blames Elliott’s boardroom overhaul for the share price slump. Such squabbles distract from the problem of competition from new rivals.

Campbell lukewarm sale pitch is begging for a cook

30 August 2018

The $12 bln soup and snack company plans to sell its fresh and international food brands, and step up cost cuts on stagnant core brands. It’s leaving the door open for a sale, but that’s unlikely to appease activists like Dan Loeb. A focused auction would be a better approach.

Trump adds new impetus to old short-termism debate

17 August 2018

The U.S. president wants the SEC to examine letting public companies report earnings every six months, rather than quarterly. Plenty of others, like BlackRock’s Larry Fink, had already slammed the practice. Trump’s tweeted directive should prompt some useful independent analysis.

Icahn got it half right with Cigna battle

14 August 2018

The activist investor has backed away from his fight against the U.S. health insurer's $52 bln deal to buy Express Scripts. On merit alone, his opposition was justified. But for activists, that is no longer enough to win. Shifting shareholder rosters have changed the game.

Icahn’s late start blunts Cigna blocking campaign

7 August 2018

The activist makes a good case for rejecting the insurer’s $52 bln Express Scripts deal. Yet his argument - Cigna is paying too much for a target threatened by regulation and Amazon - was evident months ago. And the window for enlisting other arbs to his side has already closed.

Icahn dusts off early playbook chapter with Cigna

2 August 2018

Company launches bad deal. Stock falls. Activist buys, shorts target, lobbies to unwind deal. Buyer stock goes up, seller plunges. Investor rejoices. Icahn did it with Mylan – and now he can repeat with Cigna’s value-destructive Express Scripts purchase. Plus ça change.

Hammerson tinkering reflects strategic impasse

24 July 2018

The UK landlord needed to atone for an Intu deal U-turn and its spurning of a Klepierre merger. A buyback and flogging 1.1 bln pounds of assets doesn’t quite do so. The problem is that even at their lowly valuation selling more UK assets looks hard to do.

Premier Foods CEO heave looks like M&A appetiser

10 July 2018

Activist Oasis has upped its stake in the maker of OXO cubes to oust boss Gavin Darby. Its plan to sell Batchelors soup could cut borrowing and loosen top investor Nissin’s grip, making the rest a takeover target. It’s a more appealing prospect than low growth and high debt.

UK shareholder battle upsets activist conventions

9 July 2018

Unhappy investors typically push for CEOs to step down. At infrastructure firm Stobart, fund manager Neil Woodford tried to get the chairman sacked. Iain Ferguson narrowly survived with help from rival Invesco. But the brawl puts little faith in investors guiding quiet change.

Dan Loeb hits limits of “constructivism” on Nestlé

2 July 2018

A year after disclosing a stake, the activist investor called on the Swiss giant to shake up its business and board. Though his ideas make sense, progress has been slow and the stock has lagged. He could take a more muscular approach, but only if other shareholders go along.

Premier Foods’ Japanese flavour has turned stale

28 June 2018

Top shareholder Nissin’s stake in the Mr Kipling maker has fared poorly, but a beneficial commercial deal ensures its support. With activist Oasis pushing for CEO Gavin Darby’s ouster, it’s time for the Tokyo-based company to start thinking like an investor.

Activism and stubbornness collide at SandRidge

18 June 2018

Carl Icahn’s fight with the $550 million oil driller will dominate its annual meeting this week. Neither has a straightforward plan for ending shareholders’ misery. Meanwhile a takeover by rival Midstates could slip away. The priority should be to get that deal off the ground.

Renault M&A race sidelines governance niceties

15 June 2018

Investors backed CEO Carlos Ghosn’s pay despite the French state’s opposition. His 7.4 million euro package was greased with soft targets. Yet the high proportion of shares at least gives Ghosn an extra incentive to push for a value-boosting merger with Japan’s Nissan.

Elliott didn’t get into activism to make friends

11 June 2018

Paul Singer’s hedge fund wants board seats at $31 bln utility Sempra, and has accused it of over-expanding. Presumably that includes the Oncor deal Elliott itself backed last year. Singer is arguably helping Sempra again, though the target’s board may not feel that way.

Athenahealth moves from trauma to cure

6 June 2018

The underperforming healthcare-software firm has removed CEO Jonathan Bush shortly after he admitted hitting his ex-wife. The company is looking for a replacement, but a stalking-horse bid from activist Elliott Management could lead to a sale. Either could address what ails it.

Facebook’s top two get a muddled message

5 June 2018

Most independent shareholders elected to nix the social network’s super voting rights. Yet they voiced approval for Mark Zuckerberg and Sheryl Sandberg. The strong showing for the boss and COO undercuts the argument to scrap the structure that keeps them entrenched.

Shareholder climate activism needs more heat

5 June 2018

Owners of companies from Exxon to Rite Aid are asking for more disclosure on sustainability. That’s important, but insufficient. Ensuring bosses take climate goals seriously requires an informed board – and exec pay tied to green goals. These are what investors should target.